Financials
- Market Capitalization 12.33 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-35.68
Fiyat/satışlar oranı
10.67
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 759 | EXEL Exelixis, Inc. - Common Stock | 54.45 USD | -1.47% | +1.04% | -2.35% | +39.47% | 13.49 B USD | ||
| 799 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 64.67 USD | -0.95% | -2.85% | +7.11% | +10.74% | 12.52 B USD | ||
| 810 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | -3.57% | +55.21% | 12.31 B USD | ||
| 823 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 84.91 USD | -4.15% | -2.14% | -2.32% | +117.16% | 11.99 B USD |